Case number 1:17-cv-00998
Mitsubishi Tanabe Pharma Corp. et al v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 18, 2017 | 9 | Patent/Trademark Report to Commissioner (1) |
| Dec 18, 2017 | N/A | Terminated Case (0) Docket Text: CASE CLOSED (mdb) |
| Dec 18, 2017 | 9 | Dismissal (2) |
| Dec 18, 2017 | 9 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # (1) Dismissal)(mdb) |
| Dec 12, 2017 | 8 | Notice of Voluntary Dismissal (2) Docket Text: NOTICE of Voluntary Dismissal by Cilag GmbH International, Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc., Janssen Research and Development, LLC, Mitsubishi Tanabe Pharma Corp. as to Teva Pharmaceuticals USA, Inc. (Smith, Rodger) |
| Nov 8, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [7] STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint for Patent Infringement to December 12, 2017 filed by Janssen Pharmaceutica NV, Cilag GmbH International, Janssen Pharmaceuticals, Inc., Janssen Research and Development, LLC, Mitsubishi Tanabe Pharma Corp., Set/Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 12/12/2017.. Ordered by Judge Gregory M. Sleet on 11/8/2017. (mdb) |
| Nov 6, 2017 | 7 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint for Patent Infringement to December 12, 2017 - filed by Cilag GmbH International, Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc., Janssen Research and Development, LLC, Mitsubishi Tanabe Pharma Corp.. (Smith, Rodger) |
| Oct 16, 2017 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Mitsubishi Tanabe Pharma Corp., Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica NV, Janssen Research and Development, LLC, Cilag GmbH International. Teva Pharmaceuticals USA, Inc. served on 10/16/2017, answer due 11/6/2017. (Smith, Rodger) |
| Jul 26, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:17-cv-00990-GMS, 1:17-cv-00998-GMS (rjb) |
| Jul 21, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 7/21/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (jcs) |
| Jul 21, 2017 | 1 | Complaint (8) |
| Jul 21, 2017 | 1 | Exhibit A-B (24) |
| Jul 21, 2017 | 1 | Civil Cover Sheet (1) |
| Jul 21, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) |
| Jul 21, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 8, 2017. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 9/29/2020. (jcs) |
| Jul 21, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,943,582; 8,513,202. (jcs) |
| Jul 21, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Cilag GmbH International, Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc., Janssen Research and Development, LLC; Corporate Parent Mitsubishi Chemical Holdings Corporation for Mitsubishi Tanabe Pharma Corp. filed by Cilag GmbH International, Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc., Janssen Research and Development, LLC, Mitsubishi Tanabe Pharma Corp. (jcs) |
| Jul 21, 2017 | 1 | Main Document (8) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2187403.) - filed by Mitsubishi Tanabe Pharma Corp., Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica NV, Janssen Research and Development, LLC, Cilag GmbH International. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(jcs) |
| Jul 21, 2017 | 1 | Complaint* (1) |
